Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38701350

Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2024 Jul 9
First author
Masetti R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Masetti R
      type
      Author
    2. name
      Baccelli F
      type
      Author
    3. name
      Leardini D
      type
      Author
    4. name
      Locatelli F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Masetti R
      type
      Author
    2. name
      Baccelli F
      type
      Author
    3. name
      Leardini D
      type
      Author
    4. name
      Locatelli F
      type
      Author
    bibliography ids
    1. nci-bib-89918c6c51d4074a325d2348
    book metadata
    content sha256
    4c2b5ba2d030d15813916428621645eb360e6441019a6ccf318d3dc05e5b4653
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2023012041
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38701350
    immutable id
    pubmed:38701350@4c2b5ba2d030d15813916428621645eb360e6441019a6ccf318d3dc05e5b4653
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    13
    name
    Blood advances
    nlm unique id
    101698425
    pages
    3583-3595
    volume
    8
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38701350
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      e148f3803aa63984f8fa8e7d9b064d14d68df387914a3f5e093b395fb2806dee
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Jul 9
      precision
      day
      year
      2024
      publication types
      1. Journal Article
      2. Review
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38701350/
      title
      Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?

      Preserved source evidence · Not medical advice